Selenium, selenoproteins, and immunity

JC Avery, PR Hoffmann - Nutrients, 2018 - mdpi.com
Selenium is an essential micronutrient that plays a crucial role in development and a wide
variety of physiological processes including effect immune responses. The immune system …

Control of metastasis by NK cells

A López-Soto, S Gonzalez, MJ Smyth, L Galluzzi - Cancer cell, 2017 - cell.com
The metastatic spread of malignant cells to distant anatomical locations is a prominent
cause of cancer-related death. Metastasis is governed by cancer-cell-intrinsic mechanisms …

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

L Ferrari de Andrade, RE Tay, D Pan, AM Luoma, Y Ito… - Science, 2018 - science.org
MICA and MICB are expressed by many human cancers as a result of cellular stress, and
can tag cells for elimination by cytotoxic lymphocytes through natural killer group 2D …

Driving CAR T-cells forward

HJ Jackson, S Rafiq, RJ Brentjens - Nature reviews Clinical oncology, 2016 - nature.com
The engineered expression of chimeric antigen receptors (CARs) on the surface of T cells
enables the redirection of T-cell specificity. Early clinical trials using CAR T cells for the …

Development of immuno-oncology drugs—from CTLA4 to PD1 to the next generations

A Hoos - Nature reviews Drug discovery, 2016 - nature.com
Since the regulatory approval of ipilimumab in 2011, the field of cancer immunotherapy has
been experiencing a renaissance. This success is based on progress in both preclinical and …

The role of cancer-derived microRNAs in cancer immune escape

M Yi, L Xu, Y Jiao, S Luo, A Li, K Wu - Journal of hematology & oncology, 2020 - Springer
During malignant transformation, accumulated somatic mutations endow cancer cells with
increased invasiveness and immunogenicity. Under selective pressure, these highly …

Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment

T Courau, J Bonnereau, J Chicoteau, H Bottois… - … for immunotherapy of …, 2019 - Springer
Background Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant
functional assays aimed at studying these failures and the efficacy of cancer immunotherapy …

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

J Hsu, JJ Hodgins, M Marathe… - The Journal of …, 2018 - Am Soc Clin Investig
Checkpoint blockade immunotherapy targeting the PD-1/PD-L1 inhibitory axis has produced
remarkable results in the treatment of several types of cancer. Whereas cytotoxic T cells are …

Adoptive transfer of NKG2D CAR mRNA-engineered natural killer cells in colorectal cancer patients

L Xiao, D Cen, H Gan, Y Sun, N Huang, H Xiong, Q Jin… - Molecular Therapy, 2019 - cell.com
By fusing the extracellular domain of the natural killer (NK) cell receptor NKG2D to DAP12,
we constructed a chimeric antigen receptor (CAR) to improve NK cell tumor responses. An …

The function of NK cells in tumor metastasis and NK cell-based immunotherapy

Y Yu - Cancers, 2023 - mdpi.com
Simple Summary Innate immune natural killer (NK) cells are capable of killing metastatic
cancer cells without activation by antigen-presenting cells beforehand. The cytotoxic effects …